英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

gantlet    音标拼音: [g'ɔntlət]
n. 长手套;笞刑

长手套;笞刑

gantlet
n 1: to offer or accept a challenge; "threw down the gauntlet";
"took up the gauntlet" [synonym: {gauntlet}, {gantlet}]
2: a glove of armored leather; protects the hand [synonym:
{gauntlet}, {gantlet}, {metal glove}]
3: a glove with long sleeve [synonym: {gauntlet}, {gantlet}]
4: the convergence of two parallel railroad tracks in a narrow
place; the inner rails cross and run parallel and then
diverge so a train remains on its own tracks at all times
5: a form of punishment in which a person is forced to run
between two lines of men facing each other and armed with
clubs or whips to beat the victim [synonym: {gauntlet},
{gantlet}]

Gantlet \Gant"let\, n.
A glove. See {Gauntlet}.
[1913 Webster]


Gantlet \Gant"let\, n. [Gantlet is corrupted fr. gantlope;
gantlope is for gatelope, Sw. gatlopp, orig., a running down
a lane; gata street, lane lopp course, career, akin to
l["o]pa to run. See {Gate} a way, and {Leap}.]
A military punishment formerly in use, wherein the offender
was made to run between two files of men facing one another,
who struck him as he passed.
[1913 Webster]

{To run the gantlet}, to suffer the punishment of the
gantlet; hence, to go through the ordeal of severe
criticism or controversy, or ill-treatment at many hands.
[1913 Webster]

Winthrop ran the gantlet of daily slights.
--Palfrey.
[1913 Webster]

Note: Written also, but less properly, gauntlet.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
Gantlet查看　Gantlet　在百度字典中的解释百度英翻中〔查看〕
Gantlet查看　Gantlet　在Google字典中的解释Google英翻中〔查看〕
Gantlet查看　Gantlet　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • FDA approves cemiplimab-rwlc for adjuvant treatment of . . .
    On October 8, 2025, the Food and Drug Administration approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals Inc ) for the adjuvant treatment of adults with cutaneous squamous cell carcinoma
  • Libtayo® (cemiplimab-rwlc) Approved in the U. S. as First and . . .
    Libtayo® (cemiplimab-rwlc) Approved in the U S as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation
  • FDA Approves Libtayo for Adjuvant Treatment of High-Risk CSCC
    The Food and Drug Administration (FDA) has approved Libtayo ® (cemiplimab-rwlc) for the adjuvant treatment of adult patients with cutaneous squamous cell carcinoma (CSCC) at high risk of
  • FDA Approves Cemiplimab as Adjuvant Immunotherapy for High . . .
    Key Takeaways Cemiplimab-rwlc (Libtayo) is the first FDA-approved immunotherapy for high-risk CSCC post-surgery and radiation, reducing recurrence risk by 68% The phase 3 C-POST trial showed cemiplimab significantly improved 24-month disease-free survival compared to placebo Cemiplimab's safety profile aligns with its use in other skin cancers, with common adverse events including rash and
  • FDA approves Regenerons Libtayo for high-risk CSCC
    The US Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ fully human monoclonal antibody Libtayo (cemiplimab-rwlc) as an adjuvant therapy for adults with cutaneous squamous cell carcinoma (CSCC) The approval is intended for patients who face an increased risk of the disease returning after surgery and radiation
  • LIBTAYO® (cemiplimab-rwlc) | Official HCP Website
    LIBTAYO® (cemiplimab-rwlc) is a prescription medicine indicated for the treatment of adult patients with advanced NSCLC, CSCC, BCC, and as an adjuvant treatment for high-risk CSCC See Important Safety full Prescribing Information
  • Libtayo (cemiplimab-rwlc) FDA Approval History - Drugs. com
    FDA approval history for Libtayo (cemiplimab-rwlc) used to treat Squamous Cell Carcinoma, Basal Cell Carcinoma, Non Small Cell Lung Cancer Supplied by Sanofi
  • Cemiplimab Gains FDA Approval for Adjuvant High-Risk CSCC
    The FDA has approved adjuvant cemiplimab (Libtayo) for adults with high-risk cutaneous squamous-cell carcinoma after surgery and radiation
  • label - accessdata. fda. gov
    LIBTAYO (cemiplimab-rwlc) injection for intravenous use is a sterile, preservative-free, clear to slightly opalescent, colorless to pale yellow solution with a pH of 6
  • FDA Approves Libtayo as First Immunotherapy for Adjuvant . . .
    FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of CSCC Libtayo® (cemiplimab-rwlc) Approved in the U S as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation





中文字典-英文字典  2005-2009